Assyro AI

FDA Orange Book · active-ingredient family

Sodium tetradecyl sulfate

Sodium tetradecyl sulfate is approved as 1 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:SOTRADECOL · NDA 005970

1

Brand (NDA)

2

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable

ProductApplicantApplicationTEApproved
SOTRADECOLRLD×2ELKINS SINNNDA 005970Approved Prior to Jan 1, 1982

Generic (ANDA) products (2)

ProductApplicantApplicationTEApproved
SODIUM TETRADECYL SULFATEHIKMAANDA 209937APDec 09, 2019
SOTRADECOL×2MYLAN INSTITUTIONALANDA 040541Nov 12, 2004

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Sodium tetradecyl sulfate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.